Cautionary Note Regarding Forward Looking Statements
This communication includes forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act, as amended, and the
Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements related to the Company, H&E and the proposed acquisition of H&E by the Company that involve substantial risks, uncertainties and assumptions that
could cause actual results to differ materially from those expressed or implied by such statements. Forward-looking statements in this communication include, among other things, statements about the potential benefits of the proposed transaction,
the Companys plans, objectives, expectations and intentions, the financial condition, results of operations and business of each of the Company and H&E, expected valuation and re-rating opportunities
for the combined company, and the anticipated timing of closing of the proposed transaction. Forward-looking statements are generally identified by the words estimates, expects, anticipates, projects,
plans, intends, believes, forecasts, looks, and future or conditional verbs, such as will, should, could or may, as well as variations of
such words or similar expressions. All forward-looking statements are based upon our current expectations and various assumptions and apply only as of the date of this communication. Our expectations, beliefs and projections are expressed in good
faith and we believe there is a reasonable basis for them. However, there can be no assurance that our expectations, beliefs and projections will be achieved or that the completion and anticipated benefits of the proposed transaction can be
guaranteed, and actual results may differ materially from those projected. You should not place undue reliance on forward-looking statements.
There are a
number of risks, uncertainties and other important factors that could cause our actual results to differ materially from those suggested by our forward-looking statements, including, but not limited to, (i) the possibility that the sufficient number
of H&Es shares are not validly tendered into the tender offer to meet the minimum condition; (ii) the Companys ability to implement its plans, forecasts and other expectations with respect to H&Es business after the
completion of the proposed transaction and realized expected synergies; (iii) the ability to realize the anticipated benefits of the proposed transaction, including the possibility that the expected benefits from the proposed transaction will
not be realized or will not be realized within the expected time period; (iv) the Company and H&E may be unable to obtain regulatory approvals required for the proposed transaction or may be required to accept conditions that could reduce
the anticipated benefits of the proposed transaction as a condition to obtaining regulatory approvals; (v) the length of time necessary to consummate the proposed transaction may be longer than anticipated; (vi) problems may arise in
successfully integrating the businesses of the Company and H&E, including, without limitation, problems associated with the potential loss of any key employees, customers, suppliers and other counterparties of H&E; (vii) the proposed
transaction may involve unexpected costs, including, without limitation, the exposure to any unrecorded liabilities or unidentified issues during the due diligence investigation of H&E or that are not covered by insurance, as well as potential
unfavorable accounting treatment and unexpected increases in taxes; (viii) the Companys business may suffer as a result of uncertainty surrounding the proposed transaction, any adverse effects on our ability to maintain relationships with
customers, employees and suppliers; (ix) the occurrence of any event, change to other circumstances that could give rise to the termination of the merger agreement, the failure of the closing conditions included in the merger agreement to be
satisfied, or any other failure to consummate the proposed transaction; (x) any negative effects of the announcement of the proposed transaction of the financing thereof on the market price of the Company common stock or other securities;
(xi) the industry may be